YOU’RE INVITED ••••••••••••••••••••• CBD/TRIPS: A 360 Review of Access and Benefit Sharing (ABS); Multilateral Developments and National Initiatives GENEVA, SWITZERLAND— The relationship between the Convention on Biological Diversity (CBD) and Geneva-based organizations like the World Trade Organization (WTO) and the World Intellectual Property Organization (WIPO) has garnered increasing scrutiny in recent years, particularly in the area of Access and Benefit Sharing (ABS). At the same time, little attention has been paid to the CBD’s substantial progress towards negotiation of a comprehensive International Regime to regulate sustainable use of genetic resources (GR), traditional knowledge (TK) and the fair and equitable sharing of benefits from their commercialization. Join the Institute for Policy Innovation (IPI) on Wednesday, July 9, for a policy briefing in Geneva that will provide new perspectives on the ongoing CBD negotiations that recently reached consensus on a road-map to a comprehensive International Regime by 2010 and how Geneva-based organizations and national governments can best support the CBD in its comprehensive ABS mandate. FEATURING: Timothy J. Hodges, Co-Chair Ad Hoc Open-ended Working Group on Access & Benefit Sharing, Convention on Biological Diversity Ottawa, Canada Antony Taubman, Acting Director and Head Global Intellectual Property Issues Division World Intellectual Property Organization (WIPO) Geneva, Switzerland Jayashree Watal, Counselor Intellectual Property Division World Trade Organization (WTO) Geneva, Switzerland Moderator Tom Giovanetti, President Institute for Policy Innovation (IPI) Dallas, Texas EVENT DETAILS: Wednesday, July 9, 2008 8:00 am to 9:30 am InterContinental Hotel, Paris Room Chemin du Petit-Saconnex 7 Geneva, Switzerland *Complimentary Breakfast to be Served RSVP: Erin Humiston (972) 874-5139 or erin@ipi.org -###- | ||
| Entire contents Copyright by the Institure for Policy Innovation. All rights reserved. Nothing contained herein should be construed as an attempt to influence the passage of any legislation before Congress. Full Legal Notice | ||